PPARG and multiple sclerosis: PPAR-γ agonists can control inflammation and protect neurons from degenerative diseases of the central nervous system such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis by inhibiting activated microglia and via PPAR-γ.